Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat

[1]  L. Urbán,et al.  Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig , 1998, Neuroscience.

[2]  M. Malcangio,et al.  A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats , 1998, Pain.

[3]  N. Calcutt,et al.  Spinal pharmacology of tactile allodynia in diabetic rats , 1997, British journal of pharmacology.

[4]  T. Vanderah,et al.  Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats , 1997, Pain.

[5]  M. Ramer,et al.  Rapid sprouting of sympathetic axons in dorsal root ganglia of rats with a chronic constriction injury , 1997, Pain.

[6]  D. Tomlinson,et al.  Does neuropathy develop in animal models? , 1997, Clinical neuroscience.

[7]  J. Marchand,et al.  Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons , 1996, Peptides.

[8]  A. Hama,et al.  Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts , 1996, Neuroscience.

[9]  J. Levine,et al.  C-fiber mechanical stimulus–response functions are different in inflammatory versus neuropathic hyperalgesia in the rat , 1996, Neuroscience.

[10]  N. Calcutt,et al.  Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine , 1996, Pain.

[11]  H. J. McQuay,et al.  A systematic review of antidepressants in neuropathic pain , 1996, Pain.

[12]  L. Urbán,et al.  In vitro characterization of a peripheral afferent pathway of the rat after chronic sciatic nerve section. , 1996, Journal of neurophysiology.

[13]  A. Eschalier,et al.  Daily insulin treatment relieves long-term hyperalgesia in streptozocin diabetic rats. , 1996, Neuroreport.

[14]  D. Ishii,et al.  Insulin-like Growth Factors Reverse or Arrest Diabetic Neuropathy: Effects on Hyperalgesia and Impaired Nerve Regeneration in Rats , 1996, Experimental Neurology.

[15]  A. Dray,et al.  Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 receptor antagonist treatment , 1996, Pain.

[16]  S. Nishio,et al.  Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats. , 1996, Japanese journal of pharmacology.

[17]  P. V. D. Sloot,et al.  Distal tibial mononeuropathy in diabetic and nondiabetic rats reared on wire cages: an experimental entrapment neuropathy , 1995, Brain Research.

[18]  Dawn Carroll,et al.  Anticonvulsant drugs for management of pain: a systematic review , 1995, BMJ.

[19]  N. Calcutt,et al.  Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. , 1995, European journal of pharmacology.

[20]  R. Myers,et al.  Quantitative Neuropathology of a Focal Nerve Injury Causing Hyperalgesia , 1995, Journal of neuropathology and experimental neurology.

[21]  P. Calissi,et al.  Peripheral Diabetic Neuropathy: Current Concepts in Treatment , 1995, The Annals of pharmacotherapy.

[22]  N. Bowery,et al.  Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy , 1995, Brain Research.

[23]  M. Byas-Smith,et al.  Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design , 1995, Pain.

[24]  K. Kajander,et al.  Quantitative evaluation of calcitonin gene-related peptide and substance P levels in rat spinal cord following peripheral nerve injury , 1995, Neuroscience Letters.

[25]  J. Wright,et al.  Review of the Symptomatic Treatment of Diabetic Neuropathy , 1994, Pharmacotherapy.

[26]  N. Calcutt,et al.  Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats , 1994, Pain.

[27]  J. Levine,et al.  Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. , 1994, Journal of neurophysiology.

[28]  A. Eschalier,et al.  Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics , 1994, Pain.

[29]  S. Maier,et al.  The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry , 1994, Brain Research.

[30]  N. Calcutt,et al.  Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats , 1993, Neuroscience Letters.

[31]  A. Eschalier,et al.  RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats. , 1993, European journal of pharmacology.

[32]  J. Levine,et al.  Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained , 1993, Brain Research.

[33]  J. Hauw,et al.  Time course of degeneration and regeneration of myelinated nerve fibres following chronic loose ligatures of the rat sciatic nerve: can nerve lesions be linked to the abnormal pain-related behaviours? , 1993, Pain.

[34]  A. Eschalier,et al.  Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain , 1993, Pain.

[35]  J. Levine,et al.  Mechanical hyperalgesia in streptozotocin-diabetic rats , 1993, Neuroscience.

[36]  G. Bennett,et al.  Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. , 1992, Journal of neurophysiology.

[37]  R. Mccarty,et al.  Pain threshold in diabetic rats: effects of good versus poor diabetic control , 1992, Pain.

[38]  G. Bennett,et al.  Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat , 1992, Neuroscience Letters.

[39]  G. Willars,et al.  Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition , 1992, Neuroscience Letters.

[40]  M. Max,et al.  Transdermal clonidine versus placebo in painful diabetic neuropathy , 1992, Pain.

[41]  Ronald Dubner,et al.  A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.

[42]  S. Yagihashi,et al.  Effects of Long-Term Aldose Reductase Inhibition on Development of Experimental Diabetic Neuropathy: Ultrastructural and Morphometric Studies of Sural Nerve in Streptozocin-Induced Diabetic Rats , 1990, Diabetes.

[43]  S. Yagihashi,et al.  Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. , 1990, The American journal of pathology.

[44]  R. Hellweg,et al.  Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy , 1990, Journal of neuroscience research.

[45]  R. Mccarty,et al.  Glycemic control of pain threshold in diabetic and control rats , 1990, Physiology & Behavior.

[46]  A. Wein,et al.  Length-tension relationship of urinary bladder strips from streptozotocin-diabetic rats. , 1990, Pharmacology.

[47]  A. Wein,et al.  The influence of intravesical volume upon contractile responses of the whole bladder preparation from streptozotocin-diabetic rats. , 1990, General pharmacology.

[48]  Z. Seltzer,et al.  Effect of Hyperglycemia on Pain Perception and on Efficacy of Morphine Analgesia in Rats , 1988, Diabetes.

[49]  T. Vilén,et al.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. , 1988, The New England journal of medicine.

[50]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[51]  D. Greene,et al.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. , 1988, The Journal of clinical investigation.

[52]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[53]  G. Burnstock,et al.  A study of bladder dysfunction during streptozotocin-induced diabetes in the rat using an in vitro whole bladder preparation. , 1987, The Journal of urology.

[54]  M. Lewis,et al.  Streptozocin Diabetes Alters Immunoreactive β-Endorphin Levels and Pain Perception After 8 wk in Female Rats , 1986, Diabetes.

[55]  S. Leu,et al.  Alterations in Physiologic Functions and in Brain Monoamine Content in Streptozocin-Diabetic Rats , 1986, Diabetes.

[56]  L. C. Russell,et al.  Spontaneous Activity of Primary Afferent Neurons in Diabetic BB/Wistar Rats: A Possible Mechanism of Chronic Diabetic Neuropathic Pain , 1985, Diabetes.

[57]  C. Messow,et al.  Urethral plug-a new secondary male sex characteristic in rat and other rodents , 1982, Laboratory animals.

[58]  D. Greene,et al.  Distal neuropathy in experimental diabetes mellitus , 1980, Annals of neurology.

[59]  N. Rakieten.  Studies on the diabetogenic action of streptozotocin , 1963 .